欧洲药典适用性证书数据库（欧盟CEP认证）

专论编号	物质名称	证书持有人	持有人ORG-ID和LOC-ID	证书编号	发布日期	证书状态	到期续期	证书类型	上一程序的结束日期	历史数据程序类型\|结论\|日期
1140	Potassium clavulanate	SINOPHARM WEIQIDA PHARMACEUTICAL CO., LTD Datong CN	100033465;100082197	CEP 2014-320 - Rev 01	2025/06/02	Valid		Chemical	2025/06/02	Minor revision\|CEP granted\|02/06/2025; Renewal\|CEP granted\|05/03/2021
654	Beclometasone dipropionate	AVIK PHARMACEUTICAL LIMITED Vapi IN	100023327;100041968	CEP 2014-036 - Rev 02	2025/06/02	Valid		Chemical	2025/06/02	Minor revision\|CEP granted\|02/06/2025; Major revision\|CEP granted\|30/07/2024; Notification\|Accepted - CEP remains valid\|17/06/2022; Renewal\|CEP granted\|03/11/2020
1705	Sertraline hydrochloride	SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN	100008538;100018201	CEP 2008-265 - Rev 02	2025/06/02	Valid		Chemical	2025/06/02	Minor revision\|CEP granted\|02/06/2025; Notification\|Accepted - CEP remains valid\|28/07/2021; Minor revision\|Accepted - CEP remains valid\|05/01/2021; Notification\|CEP granted\|27/05/2020
576	Allopurinol	IPCA LABORATORIES LIMITED Mumbai IN	100011685;100018680	CEP 2008-211 - Rev 05	2025/06/02	Valid		Chemical	2025/06/02	Minor revision\|CEP granted\|02/06/2025; Minor revision\|Accepted - CEP remains valid\|12/03/2024; Minor revision\|CEP granted\|27/01/2023; Minor revision\|Accepted - CEP remains valid\|21/02/2022; Minor revision\|CEP granted\|19/08/2020
729	Naloxone hydrochloride dihydrate	NORAMCO, LLC. Wilmington US	100048651;100080628	CEP 2011-055 - Rev 04	2025/06/02	Valid		Chemical	2025/06/02	Minor revision\|CEP granted\|02/06/2025; Minor revision\|CEP granted\|06/09/2023; Notification\|CEP granted\|18/03/2022; Notification\|CEP granted\|05/03/2020
3139	Brivaracetam	ALIVUS LIFE SCIENCES LIMITED Mumbai IN	100023468;100069944	CEP 2024-088 - Rev 00	2025/06/02	Valid	02/06/2030	Chemical	2025/06/02	New application\|CEP granted\|02/06/2025
2760	Brimonidine tartrate	MICRO LABS LIMITED Bengaluru IN	100017819;100077269	CEP 2019-335 - Rev 03	2025/06/02	Valid		Chemical	2025/06/02	Renewal\|CEP granted\|02/06/2025; Notification\|CEP granted\|18/04/2024; Major revision\|CEP granted\|07/02/2022; Minor revision\|Rejected\|17/11/2021
1354	Oxybutynin hydrochloride	THINQ PHARMA-CRO LIMITED Thane IN	100042194;100069636	CEP 2024-057 - Rev 00	2025/06/02	Valid	02/06/2030	Chemical	2025/06/02	New application\|CEP granted\|02/06/2025
714	Doxorubicin Hydrochloride	DZD (HEZE) PHARMACEUTICAL CO., LTD. Heze City CN	100039412;100062056	CEP 2016-254 - Rev 01	2025/06/02	Valid		Chemical	2025/06/02	Minor revision\|CEP granted\|02/06/2025; Renewal\|CEP granted\|22/11/2022
2849	Hydroxychloroquine sulfate	ZYDUS LIFESCIENCES LIMITED Vadodara IN	100005979;100074301	CEP 2019-011 - Rev 02	2025/06/02	Valid		Chemical	2025/10/24	Minor revision\|Accepted - CEP remains valid\|24/10/2025; Renewal\|CEP granted\|02/06/2025; Minor revision\|Accepted - CEP remains valid\|20/09/2024; Notification\|CEP granted\|08/07/2022; Minor revision\|Accepted - CEP remains valid\|15/09/2020
2992	Lacosamide, Process II	APITORIA PHARMA PRIVATE LIMITED Hyderabad IN	100049668;100086364	CEP 2024-128 - Rev 02	2025/06/02	Valid	04/07/2029	Chemical	2025/06/02	Administrative procedure\|CEP granted\|02/06/2025; Minor revision\|CEP granted\|26/05/2025; New application\|CEP granted\|04/07/2024
3095	Dabigatran etexilate mesilate, Form-I	ZYDUS LIFESCIENCES LIMITED Vadodara IN	100005979;100074301	CEP 2024-262 - Rev 00	2025/06/02	Valid	02/06/2030	Chemical	2025/06/02	New application\|CEP granted\|02/06/2025
2762	Capecitabine, Process-III	INTAS PHARMACEUTICALS LIMITED Ahmedabad IN	100011529;100023432	CEP 2025-176 - Rev 00	2025/06/02	Valid	02/06/2030	Chemical	2025/06/02	New application\|CEP granted\|02/06/2025
2585	Rizatriptan benzoate, 1295	MACLEODS PHARMACEUTICALS LIMITED Mumbai IN	100021441;100077265	CEP 2025-054 - Rev 00	2025/06/02	Valid	02/06/2030	Chemical	2025/06/02	New application\|CEP granted\|02/06/2025
778	Oxazepam	R.L. FINE CHEM PRIVATE LIMITED Chikkaballapur IN	100016723;100053383	CEP 2024-383 - Rev 00	2025/06/02	Valid	02/06/2030	Chemical	2025/06/02	New application\|CEP granted\|02/06/2025
2173	Gabapentin, Process V	ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Taizhou CN	100011833;100018698	CEP 2024-148 - Rev 01	2025/06/02	Valid	19/07/2029	Chemical	2025/06/02	Minor revision\|CEP granted\|02/06/2025; New application\|CEP granted\|19/07/2024
1558	Propofol	SI GROUP, INC. The Woodlands US	100025308;100077018	CEP 2002-229 - Rev 05	2025/05/30	Valid		Chemical	2025/05/30	Minor revision\|CEP granted\|30/05/2025; Minor revision\|CEP granted\|26/10/2023; Notification\|CEP granted\|22/08/2022
2541	Quetiapine Fumarate	MEGA FINE PHARMA PRIVATE LIMITED Mumbai IN	100011550;100021133	CEP 2014-198 - Rev 02	2025/05/30	Valid		Chemical	2025/05/30	Minor revision\|CEP granted\|30/05/2025; Minor revision\|CEP granted\|21/11/2023
1632	Celiprolol hydrochloride	MOEHS IBERICA S.L. Rubi ES	100029092;100068825	CEP 2007-220 - Rev 05	2025/05/30	Valid		Chemical	2025/05/30	Minor revision\|CEP granted\|30/05/2025; Minor revision\|CEP granted\|08/03/2024; Minor revision\|Accepted - CEP remains valid\|24/10/2022; Monograph revision\|CEP granted\|24/03/2021
2421	Ziprasidone hydrochloride monohydrate	APITORIA PHARMA PRIVATE LIMITED Hyderabad IN	100049668;100086364	CEP 2012-131 - Rev 02	2025/05/30	Valid		Chemical	2025/05/30	Minor revision\|CEP granted\|30/05/2025; Notification\|CEP granted\|11/01/2024; Minor revision\|Accepted - CEP remains valid\|17/11/2021; Minor revision\|Accepted - CEP remains valid\|29/04/2021

专论编号 (Monograph Number)
物质名称 (Substance)
证书持有人 (Certificate (CEP) Holder)
证书编号 (Certificate (CEP) Number)
证书类型 (Type CEP)
证书状态 (Status CEP)
发布日期(Issue Date CEP)	-
证书效期(End date CEP)	-